Skip to main content
. 2018 Feb 28;16:47. doi: 10.1186/s12967-018-1421-y

Fig. 1.

Fig. 1

Apatinib exhibits a dose- and time-dependent inhibition of proliferation of B and T-lineage ALL cell lines. B-lineage (a, b) and T-lineage ALL cells (c, d) were exposed to indicated concentrations of Apatinib for 48 or 72 h, and cell viability was subsequently determined by a CCK-8 kit